Mediview Mr Scan Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.19 M
as on 04-07-2024
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.09 Cr
as on 04-07-2024
- Revenue 47.69%
(FY 2023)
- Profit 54.13%
(FY 2023)
- Ebitda 74.28%
(FY 2023)
- Net Worth 97.47%
(FY 2023)
- Total Assets 155.94%
(FY 2023)
About Mediview Mr Scan
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.19 M.
The company currently has active open charges totaling ₹5.09 Cr.
Dilip Biswas and Manika Biswas serve as directors at the Company.
- CIN/LLPIN
U85195WB2002PTC094273
- Company No.
094273
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kalyani, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mediview Mr Scan?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Biswas  | Director | 21-Feb-2002 | Current |
| Manika Biswas | Director | 21-Feb-2002 | Current |
Financial Performance of Mediview Mr Scan.
Mediview Mr Scan Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.69% increase. The company also saw a substantial improvement in profitability, with a 54.13% increase in profit. The company's net worth Soared by an impressive increase of 97.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediview Mr Scan?
In 2023, Mediview Mr Scan had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mediview Diagnostic Services Private LimitedActive 26 years 11 monthsDilip Biswas and Manika Biswas are mutual person
Mediview Mrct Private LimitedActive 1 year 3 monthsDilip Biswas and Manika Biswas are mutual person
- Mediview Ct Scan Private LimitedActive 1 year 3 months
Dilip Biswas and Manika Biswas are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 20 Sep 2022 | ₹8.04 M | Open |
Hdfc Bank Limited Creation Date: 02 Feb 2017 | ₹4.29 Cr | Open |
How Many Employees Work at Mediview Mr Scan?
Unlock and access historical data on people associated with Mediview Mr Scan, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediview Mr Scan, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediview Mr Scan's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
